Medicine guide

GEFITINIB MYLAN

As listed in the register: GEFITINIB MYLAN 250 mg, comprimé pelliculé

250 mg · comprimé pelliculé

  • Prescription only
Active substance
Géfitinib
Made by
MYLAN PHARMACEUTICALS (IRLANDE)

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Details

Made byMYLAN PHARMACEUTICALS (IRLANDE)
Active substanceGéfitinib
Strength250 mg
Formcomprimé pelliculé
Routeorale
Dispensing (as stated by the register)médicament nécessitant une surveillance particulière pendant le traitement · prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE · prescription réservée aux spécialistes et services HEMATOLOGIE · prescription hospitalière · liste I · prescription réservée aux médecins compétents en CANCEROLOGIE
MarketedNo — authorised but not currently marketed, according to the register
Authorisation procedureProcédure centralisée
EU numberEU/1/18/1321
Name in the registerGEFITINIB MYLAN 250 mg, comprimé pelliculé
Packs30 plaquettes thermoformée(s) PVC PVDC aluminium de 1 comprimé
CIS65648219
CIP133400930156667

Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician

Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.